Inhibition of Farnesyltransferase as a Strategy for the Development of Novel Anti-Malarials

Publisher： Bentham Science Publishers

E-ISSN： 1875-600x|4|3|277-286

ISSN： 1568-0126

Source： Current Medicinal Chemistry - Anti-Infective Agents, Vol.4, Iss.3, 2005-07, pp. : 277-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure-Based Approaches to the Development of Novel Anti-Malarials

By  

Current Drug Targets, Vol. 5, Iss. 2, 2004-02 ,pp. : 137-149

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: The Medicinal Chemistry and Drug Development of Novel Antimalarials)

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 14, 2014-07 ,pp. : 1635-1636

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Protein Farnesyltransferase as Novel Anticancer Agents

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 3, 2002-03 ,pp. : 303-323

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapeutic strategy for breast cancer: mammalian target of rapamycin inhibition

By Yip Adrian Yun-San   Ong Eleanor Yuen-Yuen   Chow Louis Wing-Cheong  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 4, 2009-04 ,pp. : 457-466

Informa Healthcare

Access to resources Recommend Favorite

The Recent Development of Farnesyltransferase Inhibitors as Anticancer and Antimalarial Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 10, 2015-08 ,pp. : 837-857

Bentham Science Publishers

Access to resources Recommend Favorite